REG Stock Gapped up +0.24 $REG Last Price 66.55 Day High

RxMP Therapeutics Lands a DARPA Deal Would you look at that—RxMP Therapeutics just got handed a load of cash thanks to some good old government backing. Up to $10.7 million from DARPA is no chump change. It's like finding a lifeboat right when you're treading water out there in the big bad sea. This award under the RAPIID program is set to move the needle for RxMP’s...

Argentina's Oil Play: Laredo Oil's Bold Venture Talk about shooting for the stars. Laredo Oil's second tête-à-tête with Santa Cruz Province's big wigs highlights their itch to rejuvenate Argentina's tired oil fields. For folks who know the nitty-gritty of oil, we're talking about the Golfo San Jorge Basin, a place where old dogs might learn new tricks thanks to that...

Doughnut-Sized Dilemma for Duolingo Investors Falling stock prices are nothing new, but when Duolingo (NASDAQ: DUOL) tumbles 25.49% and a securities fraud class action tags along, eyebrows raise. Folks invested between May 2, 2025, and February 26, 2026, might want to dig deeper. Why? Because the alleged deception has unraveled any potential optimism these shareholders...

Endava in Hot Water Over Alleged Misleading Statements Alright, folks, gather around—there's a storm brewing over at Endava with shareholders mightier than the Greek gods, furrowing their brows with intent. You see, Schall, Brown & Schwartz LLP, a firm that practically eats legal challenges for breakfast, is beating the drums of a securities fraud lawsuit. Yep, I'm...

Adding Heavyweights to Catalyze Growth Imagine you're Misunderstood Brands, prepping your artillery before charging into the battleground of national chains. What do you do? You double down strategically by rallying the best industry minds around. Announced on October 15, 2026, this company's concocted a dream team of beverage veterans as they steer their products—like...

UNLOXCYT: A New Player in Cancer Treatment Well, here's a notch up for Sun Pharma. Their UNLOXCYT® (cosibelimab-ipdl) just got a Category 2A Preferred Designation from the NCCN for locally advanced cutaneous squamous cell carcinoma (laCSCC) patients who can't opt for surgery or radiation. And if you know anything about cancer treatment guidelines, you know that's a big...

Unveiling the LB-30 Cyclotron at EANM 2026 Life in nuclear medicine never stands still, and once again, Longevous Beamtech (LBT) is stirring the pot with its brand-new LB-30 series medical cyclotron. They rolled out this high-powered beast at the 39th Annual Congress of the European Association of Nuclear Medicine (EANM 2026) in Vienna. Leaning into the 30 MeV energy...

A Rocky Day for Endava Investors Here's the thing, on September 21, 2026, Endava plc hit a rough patch that left a mark. After the market closed, the company announced that it had put its Chief Financial Officer, Mark Thurston, on administrative leave. This wasn't just a routine shuffle; it came on the heels of the Board's Audit Committee finding reason to probe into...

The Growing Pains of Teen Driving Getting a driver's license is exciting for teens, but let's face it—the road is no playground. In 2024, a staggering 2,320 lives were lost in the U.S. due to crashes with teen drivers at the wheel. These stats aren’t just numbers—they’re grim reminders that safety isn’t a given for young drivers. Amidst this backdrop, the...

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

CEO David Solomon Receives Significant Pay Increase Goldman Sachs has recently made headlines with its decision to increase the annual compensation of CEO David Solomon to an impressive $39 million for the upcoming year. This new figure marks a notable increase from the previous year's compensation of $31 million, a change that illustrates the board's confidence in...

Revolutionizing Racecar Engineering The world of racing has always been about speed, performance, and pushing the limits of engineering. An inventive mind has stepped forward to address these needs by developing a remarkable enhanced carburetor that aims to redefine what is possible in racecars and drag racing vehicles. The inventor expressed inspiration through the...

Akari Therapeutics Welcomes Kameel D. Farag as Interim CFO Akari Therapeutics is making significant strides in the biotechnology field, particularly in oncology. The announcement of Kameel D. Farag as the Interim Chief Financial Officer marks a pivotal moment in the company’s trajectory. With over two decades of experience in the biotech sector, Farag brings a wealth of...

Realty Executives Enhances Brokerage with Unified Arizona Operations In a significant step towards strengthening its presence in the real estate market, Realty Executives International has announced the full consolidation of its Arizona operations. This landmark decision brings together the real estate markets of Phoenix and Yuma, integrating them into a single, cohesive...

Bit Origin Faces Significant Market Challenges China Xiangtai Food Co Ltd (BTOG) is currently experiencing a rough patch as its stock plummeted to a new 52-week low, now trading at $0.81. This represents a staggering decline of 79.4% over the past year. As a micro-cap company with a market value of only $6.9 million, its current performance raises alarms among investors....